LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 91.27 | 84.90 | 1013 | 7420 | 0.1365 | 0.4687 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 91.27 | 84.90 | 12165 | 7420 | 1.6394 | 1.1593 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 92.98 | 84.90 | 2902 | 7257 | 0.3999 | 0.7338 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 92.98 | 84.90 | 10174 | 7257 | 1.4018 | 1.1081 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 92.98 | 84.90 | 987 | 7257 | 0.1360 | 0.4656 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 92.98 | 84.90 | 12453 | 7257 | 1.7159 | 1.1755 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 94.68 | 84.90 | 2442 | 7000 | 0.3488 | 0.6950 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 94.68 | 84.90 | 10235 | 7000 | 1.4621 | 1.1230 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 94.68 | 84.90 | 899 | 7000 | 0.1284 | 0.4488 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 94.68 | 84.90 | 12694 | 7000 | 1.8133 | 1.1960 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 2.66 | 84.90 | 578 | 285 | 2.0228 | 1.9907 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 2.66 | 84.90 | 580 | 285 | 2.0298 | 1.9966 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 4.36 | 84.90 | 675 | 322 | 2.0926 | 1.9346 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 4.36 | 84.90 | 629 | 322 | 1.9500 | 1.8290 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 6.06 | 84.90 | 767 | 365 | 2.0988 | 1.8439 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 6.06 | 84.90 | 701 | 365 | 1.9182 | 1.7250 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 7.77 | 84.90 | 839 | 411 | 2.0402 | 1.7358 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | N08 |